A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction

被引：1

作者：

Stein, Stacey ^{[1
]}

Dooley, Kirsten ^{[2
]}

Uboha, Nataliya V. ^{[3
]}

Hochster, Howard S. ^{[4
,5
]}

机构：

[1] Yale Sch Med, New Haven, CT 06510 USA

[2] Yale Canc Ctr, New Haven, CT USA

[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA

[4] Rutgers Canc Inst, New Brunswick, NJ USA

[5] RWJBarnabas Hlth, New Brunswick, NJ USA

来源：

ONCOLOGY-NEW YORK | 2022年 / 36卷 / 07期

关键词：

gastrointestinal malignancies; oxaliplatin; hypersensitivity reaction; omalizumab; METASTATIC COLORECTAL-CANCER; DESENSITIZATION; CHEMOTHERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：414 / 419

页数：6

共 25 条

[1] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[2] FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer [J].

Ay, Seval ;

Atci, Muhammed Mustafa ;

Arikan, Rukiye ;

Dulgar, Ozgecan ;

Ozyukseler, Deniz Tataroglu ;

Paksoy, Nail ;

Dogan, Izzet ;

Oztosun, Bugra ;

Tastekin, Didem ;

Oven, Basak Bala ;

Gumus, Mahmut .

JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) :465-471

[3] Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment [J].

Brennan, Patrick J. ;

Bouza, Tito Rodriguez ;

Hsu, F. Ida ;

Sloane, David E. ;

Castells, Mariana C. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) :1259-1266

[4] Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma [J].

Busse, W ;

Corren, J ;

Lanier, BQ ;

McAlary, M ;

Fowler-Taylor, A ;

Della Cioppa, G ;

van As, A ;

Gupta, N .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :184-190

[5] Use of Omalizumab to Achieve Successful Desensitization After Oxaliplatin Anaphylaxis [J].

Cahill, K. N. ;

Harrison, P. ;

de Asis, M. ;

Castells, M. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) :AB103-AB103

[6] Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases [J].

Castells, Mariana C. ;

Tennant, Nichole M. ;

Sloane, David E. ;

Hsu, F. Ida ;

Barrett, Nora A. ;

Hong, David I. ;

Laidlaw, Tanya M. ;

Legere, Henry J. ;

Nallamshetty, Samridhi N. ;

Palis, Ross I. ;

Rao, Jayanti J. ;

Berlin, Suzanne T. ;

Campos, Susana M. ;

Matulonis, Ursula A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :574-580

[7] FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].

Conroy, T. ;

Hammel, P. ;

Hebbar, M. ;

Ben Abdelghani, M. ;

Wei, A. C. ;

Raoul, J. -L. ;

Chone, L. ;

Francois, E. ;

Artru, P. ;

Biagi, J. J. ;

Lecomte, T. ;

Assenat, E. ;

Faroux, R. ;

Ychou, M. ;

Volet, J. ;

Sauvanet, A. ;

Breysacher, G. ;

Di Fiore, F. ;

Cripps, C. ;

Kavan, P. ;

Texereau, P. ;

Bouhier-Leporrier, K. ;

Khemissa-Akouz, F. ;

Legoux, J. -L. ;

Juzyna, B. ;

Gourgou, S. ;

O'Callaghan, C. J. ;

Jouffroy-Zeller, C. ;

Rat, P. ;

Malka, D. ;

Castan, F. ;

Bachet, J. -B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406

[8] Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil [J].

deBraud, F ;

Munzone, E ;

Nole, F ;

De Pas, T ;

Biffi, R ;

Brienza, S ;

Aapro, MS .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (03) :279-283

[9] Promising option in the prevention of idiopathic anaphylaxis: Omalizumab [J].

Demirturk, Mustafa ;

Gelincik, Asli ;

Colakoglu, Bahattin ;

Dal, Murat ;

Buyukozturk, Suna .

JOURNAL OF DERMATOLOGY, 2012, 39 (06) :552-554

[10] Metastatic Colorectal Cancer: Current State and Future Directions [J].

Fakih, Marwan G. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (16) :1809-+

← 1 2 3 →